ArticleCardiology and cardiovascular medicine2022

Hydroxychloroquine Attenuates Myocardial Ischemic and Post-Ischemic Reperfusion Injury by Inhibiting the Toll-Like Receptor 9 - Type I Interferon Pathway.

Katherine M Marsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.